A diagnostic quandary: Rotavirus vaccine associated diarrhea.


Journal

Vaccine
ISSN: 1873-2518
Titre abrégé: Vaccine
Pays: Netherlands
ID NLM: 8406899

Informations de publication

Date de publication:
12 07 2023
Historique:
received: 31 01 2023
revised: 10 06 2023
accepted: 11 06 2023
medline: 1 8 2023
pubmed: 20 6 2023
entrez: 19 6 2023
Statut: ppublish

Résumé

The patient is an otherwise healthy two-month-old boy who received the recommended vaccinations for his age group, which included the rotavirus pentavalent vaccine (RV5; RotaTeq) at his two-month well child visit. Three days later, he developed prolonged non-bloody diarrhea and was found to have persistently positive rotavirus antigen in his stool. Subsequent workup revealed mild defects in his functional T-cell immunocompetence. Genetic testing was obtained through the Invitae panel and was negative for hereditary forms of primary immunodeficiencies. The rotavirus antigen was found to have cleared from his stool around four months after receiving the RV5. Unfortunately, the source of the rotavirus infection was unable to be determined. The caregivers had misconceptions about the vaccine and the child's immune system function which led to refusal of any further vaccinations. Healthcare providers should strive to develop honest and respectful relationships with parents to have thoughtful dialogues regarding vaccine safety and efficacy.

Identifiants

pubmed: 37336660
pii: S0264-410X(23)00715-6
doi: 10.1016/j.vaccine.2023.06.040
pii:
doi:

Substances chimiques

Antigens, Viral 0
Rotavirus Vaccines 0
Vaccines, Attenuated 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

4453-4456

Informations de copyright

Copyright © 2023 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Benjamin L Hamel (BL)

Department of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, MN 55902, United States. Electronic address: hamel.benjamin@mayo.edu.

Jenny Patel (J)

Department of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, MN 55902, United States.

Jenna Still (J)

Department of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, MN 55902, United States.

Avni Joshi (A)

Department of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, MN 55902, United States; Division of Pediatric Allergy and Immunology, Mayo Clinic, Rochester, MN 55902, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH